Quantifying the Cost of

Shigella cost cost of illness diarrhea health economics

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Mar 2024
Historique:
medline: 27 3 2024
pubmed: 27 3 2024
entrez: 27 3 2024
Statut: epublish

Résumé

Comparative costs of public health interventions provide valuable data for decision making. However, the availability of comprehensive and context-specific costs is often limited. The Enterics for Global Health (EFGH) EFGH working groups comprising representatives from each country (Bangladesh, Kenya, Malawi, Mali, Pakistan, Peru, and The Gambia) developed the study methods. Over a 24-month surveillance period, facility-based surveys will collect data on resource use for the medical treatment of an estimated 9800 children aged 6-35 months with diarrhea. Through these surveys, we will describe and quantify medical resources used in the treatment of diarrhea (eg, medication, supplies, and provider salaries), nonmedical resources (eg, travel costs to the facility), and the amount of caregiver time lost from work to care for their sick child. To assign costs to each identified resource, we will use a combination of caregiver interviews, national medical price lists, and databases from the World Health Organization and the International Labor Organization. Our primary outcome will be the estimated cost per inpatient and outpatient episode of medically attended Results from this study will contribute to the existing body of literature on diarrhea costing and inform future policy decisions related to investments in preventive strategies for

Sections du résumé

Background UNASSIGNED
Comparative costs of public health interventions provide valuable data for decision making. However, the availability of comprehensive and context-specific costs is often limited. The Enterics for Global Health (EFGH)
Methods UNASSIGNED
EFGH working groups comprising representatives from each country (Bangladesh, Kenya, Malawi, Mali, Pakistan, Peru, and The Gambia) developed the study methods. Over a 24-month surveillance period, facility-based surveys will collect data on resource use for the medical treatment of an estimated 9800 children aged 6-35 months with diarrhea. Through these surveys, we will describe and quantify medical resources used in the treatment of diarrhea (eg, medication, supplies, and provider salaries), nonmedical resources (eg, travel costs to the facility), and the amount of caregiver time lost from work to care for their sick child. To assign costs to each identified resource, we will use a combination of caregiver interviews, national medical price lists, and databases from the World Health Organization and the International Labor Organization. Our primary outcome will be the estimated cost per inpatient and outpatient episode of medically attended
Conclusions UNASSIGNED
Results from this study will contribute to the existing body of literature on diarrhea costing and inform future policy decisions related to investments in preventive strategies for

Identifiants

pubmed: 38532961
doi: 10.1093/ofid/ofad575
pii: ofad575
pmc: PMC10962725
doi:

Types de publication

Journal Article

Langues

eng

Pagination

S41-S47

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors report no potential conflicts.

Auteurs

Chloe Morozoff (C)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Naveed Ahmed (N)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Jobiba Chinkhumba (J)

School of Global and Public Health, Department of Health Systems and Policy, Kamuzu University of Health Sciences, Blantyre, Malawi.

Md Taufiqul Islam (MT)

Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.

Abdoulie F Jallow (AF)

Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.

Billy Ogwel (B)

Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Loyda Fiorella Zegarra Paredes (LF)

Asociación Benéfica PRISMA, Iquitos, Peru.

Doh Sanogo (D)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Hannah E Atlas (HE)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Henry Badji (H)

Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.

Naor Bar-Zeev (N)

International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Bakary Conteh (B)

Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.

Mario Güimack Fajardo (M)

Asociación Benéfica PRISMA, Iquitos, Peru.

Erika Feutz (E)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Fadima C Haidara (FC)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Mehrab Karim (M)

Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.

Adama Mamby Keita (A)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Youssouf Keita (Y)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Farhana Khanam (F)

Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.

Margaret N Kosek (MN)

Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.

Karen L Kotloff (KL)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Rebecca Maguire (R)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Ishmail S Mbutuka (IS)

Malawi Liverpool Wellcome Programme, Blantyre, Malawi.

Maureen Ndalama (M)

Malawi Liverpool Wellcome Programme, Blantyre, Malawi.

John Benjamin Ochieng (JB)

Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Collins Okello (C)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Richard Omore (R)

Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Karin F Perez Garcia (KF)

Asociación Benéfica PRISMA, Iquitos, Peru.

Farah Naz Qamar (FN)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Syed Qudrat-E-Khuda (S)

Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.

Sonia Qureshi (S)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Md Nazmul Hasan Rajib (MNH)

Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.

Wagner Valentino Shapiama Lopez (WV)

Asociación Benéfica PRISMA, Iquitos, Peru.

Shazia Sultana (S)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Desiree Witte (D)

Malawi Liverpool Wellcome Programme, Blantyre, Malawi.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

Mohammad Tahir Yousafzai (MT)

Department of Pediatrics and Child Health, Aga Khan University, Karachi, Pakistan.

Alex O Awuor (AO)

Kenya Medical Research Institute, Center for Global Health Research (KEMRI-CGHR), Kisumu, Kenya.

Nigel A Cunliffe (NA)

Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.

M Jahangir Hossain (M)

Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine, Fajara, The Gambia.

Maribel Paredes Olortegui (M)

Asociación Benéfica PRISMA, Iquitos, Peru.

Milagritos D Tapia (MD)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

K Zaman (K)

Infectious Diseases Division, International Centre for Diarrhoeal Disease Research,Bangladesh Dhaka, Bangladesh.

Arianna Rubin Means (AR)

Department of Global Health, University of Washington, Seattle, Washington, USA.

Classifications MeSH